methyl 4-[2-(2-fluoroethoxy)ethoxy]benzoate | 1269797-15-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 4-[2-(2-fluoroethoxy)ethoxy]benzoate
• CAS: 1269797-15-0
• 化学式: C₁₂H₁₅FO₄
• 分子量: 242.247
• InChiKey: MNEDHNASKJPULS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 4-[2-(2-fluoroethoxy)ethoxy]benzoate 在 水 、 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 sodium hydroxide 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 N-(4-(4-(4-cyanophenyl)piperazin-1-yl)phenyl)-4-(2-(2-fluoroethoxy)ethoxy)benzamide
  参考文献：
  名称：

  [EN] RADIOLABELED COMPOUNDS
  [FR] COMPOSÉS RADIOMARQUÉS

  摘要：

  本发明涉及式(I)的放射标记化合物，其中A、B、R1、R2中的任何一个用从3H、11C和18F中选择的放射性核素标记，并且其用于在哺乳动物中成像α-突触核蛋白和/或Abeta沉积物。

  公开号：

  WO2019121661A1
• 作为产物：
  描述：

  methyl 4-(2-(2-hydroxyethoxy)ethoxy)benzoate 在 二乙胺基三氟化硫 作用下， 以 二氯甲烷 为溶剂， 以44%的产率得到methyl 4-[2-(2-fluoroethoxy)ethoxy]benzoate
  参考文献：
  名称：

  Synthesis and Pharmacological Evaluation of Fluorine-Containing D₃ Dopamine Receptor Ligands

  摘要：

  A series of fluorine-containing N-(2-methoxyphenyl)piperazine and N-(2-fluoroethoxy)piperazine analogues were synthesized, and their affinities for human dopamine D-2, D-3, and D-4 receptors were determined. Radioligand binding studies identified five compounds, 18a, 20a, 20c, 20e, and 21e, which bind with high affinity at D-3 (K-i = 0.17-5 nM) and moderate to high selectivity for D-3 VS D-2 receptors (ranging from similar to 25-to 163-fold). These compounds were also evaluated for intrinsic activity at D-2 and D3 receptors using a forskolin-dependent adenylyl cyclase assay. This panel of compounds exhibits varying receptor subtype binding selectivity and intrinsic activity at D-2 VS D-3 receptors. These compounds may be useful for behavioral pharmacology studies on the role of D-2-like dopamine receptors in neuropsychiatric and neurological disorders. Furthermore, compound 20e, which has the highest binding affinity and selectivity for the D-3 receptor (K-i = 0.17 nM for D-3, 163-fold selectivity for D-3 VS D-2 receptors), represents a candidate fluorine-18 radiotracer for in vivo PET imaging studies on the regulation of D-3 receptor expression.

  DOI：

  10.1021/jm101323b

文献信息

• RADIOLABELED COMPOUNDS
  申请人：F. Hoffmann-La Roche AG

  公开号：EP3728234A1

  公开（公告）日：2020-10-28
• Synthesis and Pharmacological Evaluation of Fluorine-Containing D₃ Dopamine Receptor Ligands
  作者：Zhude Tu、Shihong Li、Jinquan Cui、Jinbin Xu、Michelle Taylor、David Ho、Robert R. Luedtke、Robert H. Mach

  DOI：10.1021/jm101323b

  日期：2011.3.24

  A series of fluorine-containing N-(2-methoxyphenyl)piperazine and N-(2-fluoroethoxy)piperazine analogues were synthesized, and their affinities for human dopamine D-2, D-3, and D-4 receptors were determined. Radioligand binding studies identified five compounds, 18a, 20a, 20c, 20e, and 21e, which bind with high affinity at D-3 (K-i = 0.17-5 nM) and moderate to high selectivity for D-3 VS D-2 receptors (ranging from similar to 25-to 163-fold). These compounds were also evaluated for intrinsic activity at D-2 and D3 receptors using a forskolin-dependent adenylyl cyclase assay. This panel of compounds exhibits varying receptor subtype binding selectivity and intrinsic activity at D-2 VS D-3 receptors. These compounds may be useful for behavioral pharmacology studies on the role of D-2-like dopamine receptors in neuropsychiatric and neurological disorders. Furthermore, compound 20e, which has the highest binding affinity and selectivity for the D-3 receptor (K-i = 0.17 nM for D-3, 163-fold selectivity for D-3 VS D-2 receptors), represents a candidate fluorine-18 radiotracer for in vivo PET imaging studies on the regulation of D-3 receptor expression.
• [EN] RADIOLABELED COMPOUNDS<br/>[FR] COMPOSÉS RADIOMARQUÉS
  申请人：HOFFMANN LA ROCHE

  公开号：WO2019121661A1

  公开（公告）日：2019-06-27

  The present invention relates to radiolabeled compounds of formula (I) wherein either A, B, R1, R2, is labeled with a radionuclide selected from 3H, 11C and 18F and its use for imaging alpha synuclein and/or Abeta deposits in mammals.

  本发明涉及式(I)的放射标记化合物，其中A、B、R1、R2中的任何一个用从3H、11C和18F中选择的放射性核素标记，并且其用于在哺乳动物中成像α-突触核蛋白和/或Abeta沉积物。